Standardised reporting protocol for endoscopic resection for Barrett oesophagus associated neoplasia: expert consensus recommendations

Summary Endoscopic resection (ER) is considered the therapy of choice for intraepithelial neoplasia associated with visible lesions and T1a adenocarcinoma. Pathologists are bound to encounter specimens collected via these techniques more frequently in their practice. A standardised protocol for handling, grossing, and assessing ER specimens should be adopted to ensure that all prognostic information and characteristics influencing treatment are included in reports (see Supplementary Video Abstract, http://links.lww.com/PAT/A22). The entire specimen should be appropriately oriented, processed and assessed. An ER specimen will commonly show intraepithelial neoplasia or invasive carcinoma. There are essential features that should be recorded if invasive carcinoma is found as they dictate further management and follow-up. These features are the margin status, depth of invasion, degree of differentiation and presence or absence of lymphovascular invasion. Important features such as duplication of muscularis mucosae should be recognised to avoid misinterpretation of depth of invasion. Key diagnostic and prognostic elements that are essential for optimal clinical decisions have been included in the reporting format proposed by the Structured Pathology Reporting committee of the Royal College of Pathologists of Australasia (RCPA).

[1]  Rebecca C Fitzgerald,et al.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus , 2013, Gut.

[2]  Hugh Barr,et al.  Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. , 2012, Gastroenterology.

[3]  J. Ajani,et al.  Duplicated Muscularis Mucosae Invasion has Similar Risk of Lymph Node Metastasis and Recurrence-free Survival as Intramucosal Esophageal Adenocarcinoma , 2011, The American journal of surgical pathology.

[4]  A. Hölscher,et al.  Comparison Between Endoscopic and Surgical Resection of Mucosal Esophageal Adenocarcinoma in Barrett's Esophagus At Two High-Volume Centers , 2011, Annals of surgery.

[5]  G. Ergun,et al.  The significance of "indefinite for dysplasia" grading in Barrett metaplasia. , 2011, Archives of pathology & laboratory medicine.

[6]  Gregory Y. Lauwers,et al.  Interobserver Variability in the Diagnosis of Crypt Dysplasia in Barrett Esophagus , 2011, The American journal of surgical pathology.

[7]  T. Shimoda,et al.  Proper pathologic preparation and assessment of endoscopic mucosal resection and endoscopic submucosal dissection specimens , 2011 .

[8]  F. T. ten Kate,et al.  Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens , 2010, Endoscopy.

[9]  G. Meijer,et al.  Low-Grade Dysplasia in Barrett's Esophagus: Overdiagnosed and Underestimated , 2010, The American Journal of Gastroenterology.

[10]  R. Swindell,et al.  Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro‐oesophageal junction cancers , 2010, Histopathology.

[11]  David C Whiteman,et al.  Foveolar type dysplasia in Barrett esophagus , 2010, Modern Pathology.

[12]  M. Stolte,et al.  Early Barrett's carcinoma: the depth of infiltration of the tumour correlates with the degree of differentiation, the incidence of lymphatic vessel and venous invasion , 2010, Virchows Archiv.

[13]  M. Bronner,et al.  Grading of gastric foveolar-type dysplasia in Barrett's esophagus , 2010, Modern Pathology.

[14]  S. Parsons,et al.  Barrett’s dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry , 2009, Histopathology.

[15]  N. Nishioka,et al.  Effect of Tumor Characteristics and Duplication of the Muscularis Mucosae on the Endoscopic Staging of Superficial Barrett Esophagus-related Neoplasia , 2009, The American journal of surgical pathology.

[16]  A. Krasinskas,et al.  Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. , 2009, The Annals of thoracic surgery.

[17]  大腸癌研究会 Japanese classification of colorectal carcinoma , 2009 .

[18]  A. Hölscher,et al.  Early Barrett's carcinoma of the esophagus. , 2008, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[19]  Kenneth K Wang,et al.  Muscularis Mucosae Duplication and the Musculo-fibrous Anomaly in Endoscopic Mucosal Resections for Barrett Esophagus: Implications for Staging of Adenocarcinoma , 2008, The American journal of surgical pathology.

[20]  A. Krasinskas,et al.  Duplication of the Muscularis Mucosae in Barrett Esophagus: An Underrecognized Feature and Its Implication for Staging of Adenocarcinoma , 2007, The American journal of surgical pathology.

[21]  Kenneth K Wang,et al.  Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett's Esophagus , 2007, The American Journal of Gastroenterology.

[22]  Kenneth K Wang,et al.  Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. , 2007, Gastroenterology.

[23]  Michael Vieth,et al.  Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). , 2005, Gastrointestinal endoscopy.

[24]  Carissa A. Sanchez,et al.  Crypt Dysplasia With Surface Maturation: A Clinical, Pathologic, and Molecular Study of a Barrett's Esophagus Cohort , 2006, The American journal of surgical pathology.

[25]  N. Nishioka,et al.  Endoscopic Mucosal Resection: An Improved Diagnostic Procedure for Early Gastroesophageal Epithelial Neoplasms , 2006, The American journal of surgical pathology.

[26]  M. Vieth,et al.  Pathology of early upper GI cancers. , 2005, Best practice & research. Clinical gastroenterology.

[27]  R. Cestari,et al.  Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience. , 2005, World journal of gastroenterology.

[28]  J. Ajani,et al.  Significance of the Depth of Tumor Invasion and Lymph Node Metastasis in Superficially Invasive (T1) Esophageal Adenocarcinoma , 2005, The American journal of surgical pathology.

[29]  Mari Mino-Kenudson,et al.  Management of Superficial Barrett's Epithelium-Related Neoplasms by Endoscopic Mucosal Resection: Clinicopathologic Analysis of 27 Cases , 2005, The American journal of surgical pathology.

[30]  L. Gossner,et al.  Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia. , 2004, Endoscopy.

[31]  M. Shimizu,et al.  Endoscopic mucosal resection for gastric epithelial neoplasms: a study of 39 cases with emphasis on the evaluation of specimens and recommendations for optimal pathologic analysis , 2004, Modern Pathology.

[32]  Charles J. Lightdale,et al.  The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. , 2003, Gastrointestinal endoscopy.

[33]  J. Goldblum,et al.  p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression , 2002, American Journal of Gastroenterology.

[34]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.